We are live on ! Find out more
DNLI icon

Denali Therapeutics
DNLI

148 hedge funds and large institutions have $2B invested in Denali Therapeutics in 2020 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 54 increasing their positions, 37 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

191% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 11

158% more call options, than puts

Call options by funds: $837K | Put options by funds: $324K

46% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 37

42% more capital invested

Capital invested by funds: $1.41B → $2B (+$592M)

16% more funds holding

Funds holding: 128 → 148 (+20)

2.02% more ownership

Funds ownership: 76.34% → 78.36% (+2%)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
148
Holders Change
+20
Holders Change %
+15.63%
% of All Funds
3.03%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.06%
New
32
Increased
54
Reduced
37
Closed
11
Calls
$837K
Puts
$324K
Net Calls
+$513K
Net Calls Change
+$629K

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$33.2M
2
BlackRock
BlackRock
New York
+$23.3M
3
State Street
State Street
Massachusetts
+$13.1M
4
CCM
CAAS Capital Management
New York
+$12.3M
5
UBS AM
UBS AM
Illinois
+$10M

Top Sellers

1
CM
Crestline Management
Texas
-$45.2M
2
PA
Perceptive Advisors
New York
-$14.9M
3
BCM
Bratton Capital Management
Texas
-$11.9M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$9.68M
5
MWNA
Marshall Wace North America
New York
-$7.61M
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
26
Bratton Capital Management
Texas
$10.8M -$11.9M -505,000 -53%
Jennison Associates
27
Jennison Associates
New York
$10.7M +$41.4K +1,762 +0.4%
Mitsubishi UFJ Trust & Banking
28
Mitsubishi UFJ Trust & Banking
Japan
$10.1M -$150K -6,360 -1%
American Century Companies
29
American Century Companies
Missouri
$10.1M +$5.29K +225 +0.1%
N
30
Nuveen
North Carolina
$7.97M +$1.09M +46,241 +16%
Morgan Stanley
31
Morgan Stanley
New York
$7.71M +$3.84M +163,505 +105%
Invesco
32
Invesco
Georgia
$7M -$13.9K -590 -0.2%
GPP
33
Great Point Partners
Connecticut
$6.77M +$6.58M +280,000 New
Federated Hermes
34
Federated Hermes
Pennsylvania
$6.71M +$6.52M +277,463 New
JP Morgan Chase
35
JP Morgan Chase
New York
$5.92M +$1.62M +68,843 +39%
Goldman Sachs
36
Goldman Sachs
New York
$5.51M +$2.27M +96,444 +73%
Axa
37
Axa
France
$5.45M +$875K +37,228 +20%
Principal Financial Group
38
Principal Financial Group
Iowa
$4.88M -$52.5K -2,231 -1%
MAM
39
Mark Asset Management
New York
$4.36M +$423K +17,976 +11%
Swiss National Bank
40
Swiss National Bank
Switzerland
$4.27M +$1.3M +55,400 +46%
Lord, Abbett & Co
41
Lord, Abbett & Co
New Jersey
$3.78M -$1.95M -83,108 -35%
EAM
42
Erste Asset Management
Austria
$3.42M – – –
California Public Employees Retirement System
43
California Public Employees Retirement System
California
$3.37M +$717K +30,499 +28%
TRSOTSOK
44
Teachers Retirement System of the State of Kentucky
Kentucky
$3.17M – – –
IHAM
45
Integral Health Asset Management
New York
$3.14M +$940K +40,000 +44%
Two Sigma Investments
46
Two Sigma Investments
New York
$3.04M +$2.95M +125,538 New
Citadel Advisors
47
Citadel Advisors
Florida
$2.67M +$898K +38,213 +53%
BBA
48
Baker Bros. Advisors
New York
$2.54M – – –
CS
49
Credit Suisse
Switzerland
$2.48M +$1.44M +61,340 +148%
Alkeon Capital Management
50
Alkeon Capital Management
New York
$2.42M – – –
1
2
3 4 5

DNLI Hedge Fund Activity: Q2 2020 in Review

148 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Denali Therapeutics (DNLI) for Q2 2020, worth a combined $2B — up 42% from $1.41B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new DNLI positions and 11 closed out — a net gain of 21 holders — while 54 added to existing stakes and 37 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $33.2M. The largest seller was Crestline Management, cutting an estimated $45.2M.

  • 148 institutional investors held Denali Therapeutics (DNLI) as of Q2 2020, up from 128 in Q1 2020.
  • Funds reported $2B of Denali Therapeutics stock for Q2 2020, up 42% quarter-over-quarter.
  • 32 funds opened new Denali Therapeutics positions in Q2 2020 and 11 closed out, a net change of +21 holders.
  • The largest Denali Therapeutics buyer in Q2 2020 was T. Rowe Price Associates, an estimated $33.2M added.
  • The largest Denali Therapeutics seller in Q2 2020 was Crestline Management, an estimated $45.2M sold.

Based on aggregated 13F filings for Q2 2020.